Are Options Traders Bullish on ARGX?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About ARGX

Argenx is a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. Argenx is focused on developing product candidates with the potential to be either first-in-class against novel targets or best-in-class against known, but complex, targets in order to treat diseases with a significant unmet medical need. Argenx ability to execute on this focus is enabled by its suite of differentiated technologies. Argenx SIMPLE Antibody(TM) Platform, based on the powerful llama immune system, allows it to exploit novel and complex targets, and its three antibody engineering technologies are designed to enable it to expand the therapeutic index of its product candidates.
Primary Exchange: NASDAQ

ARGX is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ADRD Invesco BLDRS Developed Markets 100 ADR Index Fund 48.2 M 4.82E+07 86 86 0.07% 0.00074 36 K 36292
ADRU Invesco BLDRS Europe Select ADR Index Fund 13.0 M 1.3E+07 74 74 0.09% 0.00089 12 K 11718
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.8 B 1.8E+09 1,028 1028 0.01% 6.61942E-05 117 K 116833

Wait, Before You Leave...